OTCMKTS:EXETF Extendicare (EXETF) Stock Price, News & Analysis $9.57 +0.29 (+3.12%) As of 02:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestBuy This Stock About Extendicare Stock (OTCMKTS:EXETF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Extendicare alerts:Sign Up Key Stats Today's Range$9.53▼$9.5750-Day Range$8.92▼$10.5452-Week Range$5.25▼$11.05Volume1,200 shsAverage Volume5,337 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield5.02%Price TargetN/AConsensus RatingHold Company Overview Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada. Read More Extendicare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreEXETF MarketRank™: Extendicare scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Extendicare.Read more about Extendicare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is -36.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is -36.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 359.6, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently decreased by 2.20%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Read more about Extendicare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 359.6, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently decreased by 2.20%, indicating that investor sentiment is improving. News and Social Media2.7 / 5News Sentiment0.77 News SentimentExtendicare has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Extendicare this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 9.44% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Receive EXETF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXETF Stock News HeadlinesExtendicare Inc. (EXETF) Q2 2025 Earnings Call Transcript4 hours ago | seekingalpha.comExtendicare Inc (EXETF) Q2 2025 Earnings Call Highlights: Strong Growth in Home Health Care ...August 8 at 8:25 AM | finance.yahoo.comTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...August 8 at 2:00 AM | InvestorPlace (Ad)Extendicare Announces 2025 Second Quarter ResultsAugust 6 at 5:52 PM | globenewswire.comHere's Why We Think Extendicare (TSE:EXE) Might Deserve Your Attention TodayJuly 18, 2025 | finance.yahoo.comExtendicare Schedules Q2 2025 Financial Results Release and Conference CallJuly 7, 2025 | tipranks.comExtendicare Announces Timing of 2025 Second Quarter Results and Conference CallJuly 7, 2025 | globenewswire.comExtendicare Acquires Closing the Gap Healthcare GroupJuly 2, 2025 | globenewswire.comSee More Headlines EXETF Stock Analysis - Frequently Asked Questions How have EXETF shares performed this year? Extendicare's stock was trading at $7.27 on January 1st, 2025. Since then, EXETF shares have increased by 31.6% and is now trading at $9.57. How do I buy shares of Extendicare? Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Ex-Dividend for 7/15 Dividend6/30/2025Record date for 7/15 Dividend7/01/2025Dividend Payable7/15/2025Ex-Dividend for 8/15 Dividend7/31/2025Record date for 8/15 Dividend8/01/2025Today8/08/2025Dividend Payable8/15/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryTrading Current SymbolOTCMKTS:EXETF CIKN/A Webwww.extendicare.com Phone(905) 470-4000FaxN/AEmployees23,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:EXETF) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.